Vietnam Institute Seeks Human Trials On Bird-Flu Vaccine
This article was originally published in PharmAsia News
A health institute has applied to Vietnam's Health Ministry to be allowed to begin human trials on an avian-influenza vaccine it has developed. The Nha Trang Institute of Vaccines and Medical Biological said it is ready for human trials following successful tests of the vaccine on animals. Backed by World Health Organization funds, the institute is building a plant capable of producing as many as a million doses of vaccine a year. A separate bird-flu trial has been testing a vaccine on Vietnamese military volunteers. (Click here for more
You may also be interested in...
A more conservative US Supreme Court may mean a less authoritative FDA, and drug pricing won’t get as much attention in the presidential campaign, which is a good thing.
The US HHS played defense on 20 September, pushing back on suggestions that secretary Alex Azar’s recent move to exert control over regulations by signing off on them was a power play aimed at the FDA. Meanwhile, former agency head Scott Gottlieb says it’s “the wrong move at the wrong time.”
With list due 4 November, there may not be time for public comment. Meanwhile, where will biopharma find fill/finish capacity?